Scotland’s pharmacy Global Sum to increase by 0.56% for 2016-17
May 16 2016
The Scottish Government has increased the available pharmacy Global Sum by £1 million to £178.359 million for 2016-17. In addition, the Non-Global Sum has been reset at £3.3 million, up £2 million on the 2015-16 sum and Drug Tariff reimbursement prices for generic drugs will remain unchanged for the financial year 2016-17.
Figures announced in NHS Circular PCA (P) (2016) 7 for margin sharing arrangements include:
- there will be an increased minimum margin achieved by community pharmacy contractors being set at £93.5 million;
- the continued delivery of risk and margin will be shared between pharmacy contractors and Health Boards on amounts above £102.171 million;
- Part 7 clawback arrangements in respect of margin to be returned to Health Boards, including legacy amounts, will be repaid over a 12-month period commencing April 2016, with the aim of keeping cashflow to a minimum of £103.078 million;
- the discount clawback rate will be set at a baseline of 3% from April 2016 and adjusted on in-year monitoring;
- any outstanding legacy amounts for return to Health Boards at March 31 2017 (inclusive of 2015-16) will be written off as agreed within the 2015-16 settlement.
Additional detailed changes to the Drug Tariff have yet to be finalised, but will be announced in due course, said Rose Marie Parr, Scotland's Chief Pharmaceutical Officer and Deputy Director, Pharmacy & Medicines Division at the Healthcare Quality and Strategy Directorate.